180 Life Sciencesの機関の所有権
180 Life Sciencesの機関の所有権は何ですか。
180 Life Sciences Corp.の機関の所有権は8.10%です。
機関の所有権の定義は何ですか。
機関所有権は、ミューチュアル・ファンドまたは年金基金、保険会社、投資会社、その他の資金を管理する他の団体が所有する会社の株式数です。
Given the considerable sums of money that institutions invest, it is not surprising that they tend to be much more knowledgeable than the average investor when it comes to the companies and industries in which they have invested.
Institutional portfolio managers often meet personally with a company's top executives, and in many cases the research they conduct is further supported by equity analysts who evaluate prospective companies and industries in great depth before making specific investment recommendations.
NASDAQのセクタHealth Careにおける機関の所有権の企業と比べる180 Life Sciences
180 Life Sciencesは何をしますか。
180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of novel drugs for unmet medical needs in chronic pain, inflammation, inflammatory diseases, and fibrosis. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and anti-tumour necrosis factor (Anti-TNF) platform, which focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.
180 Life Sciencesと類似の機関の所有権
- Wüstenrot & Württembergische AGの機関の所有権は8.08%です。
- INEOS Styrolution Indiaの機関の所有権は8.08%です。
- Asian Granito Indiaの機関の所有権は8.08%です。
- Theriva Biologics Incの機関の所有権は8.08%です。
- Exro Technologiesの機関の所有権は8.09%です。
- BlueRock Diamonds PLCの機関の所有権は8.10%です。
- 180 Life Sciencesの機関の所有権は8.10%です。
- Bastei Lübbe AGの機関の所有権は8.10%です。
- Amoeba S.Aの機関の所有権は8.10%です。
- CNFinance Ltdの機関の所有権は8.10%です。
- CITIC Telecom Internationalの機関の所有権は8.10%です。
- PAULIC Meunerie SAの機関の所有権は8.10%です。
- Liontown Resourcesの機関の所有権は8.11%です。